Tetra Radar · FDA Approvals · Decision date

VOXZOGO: FDA decision date

Biomarin Pharmaceutical Inc (BMRN) · 28 February 2027

In July 2026, we announced that the FDA accepted our sNDA for full approval of VOXZOGO in children with achondroplasia, with a PDUFA target action date of February 28, 2027.

Source: 10-Q of 3 November 2026

The decision is pending.

Biomarin Pharmaceutical Inc on Tetra Radar

A PDUFA date is the date by which the FDA has said it will decide on an application. Dates can move, and a decision is not an approval. Tetra Radar observes public information for research purposes. It does not provide investment advice.

Get the Dispatch free.